Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic stem cells.

Michael E Trigg1

  • 1Division of Blood & Bone Marrow Transplantation, Department of Pediatrics, Alfred I. duPont Hospital for Children, Wilmington, Delaware 19803, USA. mtrigg@nemours.org

Pediatrics
|April 3, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chemotherapy-induced nausea and vomiting: antiemetic trials that impacted clinical practice.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2010
Same author

Ten-year survival of children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.

Leukemia & lymphoma·2008
Same author

Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2006
Same author

A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2006
Same author

A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.

Blood·2004
Same author

Preparative therapies used for those with Fanconi's anemia undergoing stem cell transplants and subsequent engraftment rates.

Hematology (Amsterdam, Netherlands)·2003
Same journal

Severe Postoperative Hypernatremia in an Adolescent Following Sleeve Gastrectomy.

Pediatrics·2026
Same journal

Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

Pediatrics·2026
Same journal

Blood Lead Testing Among Children Enrolled in Medicaid.

Pediatrics·2026
Same journal

From Screening to Support: Crafting Social Needs Response Systems That Work for Families.

Pediatrics·2026
Same journal

A Social Care Intervention in Pediatric Practices: A Stepped Wedge Cluster Trial.

Pediatrics·2026
Same journal

Pediatric Cheerleading-Related Head Injuries and the "Double Down" Rule Change.

Pediatrics·2026
See all related articles

Children recover well from severe aplastic anemia and stem cell transplants, but face risks from infections during recovery. Further research is needed on their susceptibility to environmental toxicants.

Area of Science:

  • Pediatric Hematology and Immunology
  • Stem Cell Transplantation Science

Background:

  • The pediatric hematopoietic system develops resilience to environmental exposures over time.
  • Severe aplastic anemia, sometimes linked to toxins or infections, offers insights into hematopoietic system maturation.
  • Hematopoietic stem cell transplantation (HSCT) allows comprehensive study of hematopoietic and immunologic system reconstitution.

Purpose of the Study:

  • To examine the recovery process and associated risks in children undergoing HSCT for severe aplastic anemia.
  • To understand the unique challenges faced by pediatric patients post-transplant, particularly regarding immune deficiencies.
  • To highlight the need for more data on environmental toxicant susceptibility in recovering children.

Main Methods:

  • Observational study focusing on pediatric patients undergoing HSCT.

Related Experiment Videos

  • Analysis of recovery patterns and complications in children compared to adults.
  • Review of existing literature on environmental exposures and immune reconstitution post-transplant.

    • Main Results:

    • Children generally recover from severe aplastic anemia and HSCT more effectively than adults, with fewer complications.
    • The primary risks for recovering children include diminished resistance to viral and opportunistic infections.
    • Limited data exists on the long-term susceptibility of these children to environmental toxicants during their prolonged recovery phase.

    Conclusions:

    • Pediatric HSCT patients demonstrate robust recovery but require vigilant management of infectious risks.
    • The immune and hematopoietic system deficiencies during recovery present significant, primarily infectious, environmental challenges for children.
    • Further investigation into the impact of environmental toxicants on pediatric HSCT survivors is crucial for comprehensive care.